文献速递临床试验与 GCP真实世界研究与卫生经济

南非 scalable ART 递送干预的序贯多阶段随机分配试验:SMART ART 研究

A Sequential Multiple Assignment Randomized Trial of scalable interventions for ART delivery in South Africa: the SMART ART study.
PubMed 文献 · Trials · 2023-01-17

研究在南非夸祖鲁-纳塔尔省开展序贯多阶段随机分配试验,计划纳入最多900名符合抗逆转录病毒治疗(ART)条件但未持续参与照护的HIV感染者,比较诊所激励、社区智能柜和家庭递送等差异化服务递送方式,主要评估18个月时病毒抑制比例,并评价客户与提供者偏好及成本效果。

要点

  • 研究针对可检测病毒载量和/或未持续参与照护的HIV感染者测试适应性ART递送。
  • 计划纳入最多900名符合ART条件但未持续参与照护的HIV感染者。
  • 主要结局为18个月时达到病毒抑制的ART符合条件者比例。

核心结论

  • 需要响应性差异化服务递送干预以提高可检测病毒载量者的病毒抑制。
  • 序贯多阶段随机分配试验设计有助于评估阶梯式、适应性方法,为最需要有效且高效HIV照护策略的患者提供合适干预。

研究设计与样本

  • 在南非夸祖鲁-纳塔尔省开展的序贯多阶段随机分配试验。
  • 计划纳入最多900名符合ART条件但未持续参与照护的HIV感染者。
  • 试验注册于ClinicalTrials.gov NCT05090150,注册日期2021年10月22日。

主要发现

  • 可检测病毒载量导致HIV相关疾病、死亡和HIV传播。
  • 错过工资、交通费用和诊所就诊及ART取药等待时间长等照护障碍与可检测病毒载量相关。

关键数值与推荐

  • 研究评估的差异化服务递送类型包括诊所激励、社区智能柜和家庭递送。
  • 主要评估指标为18个月时达到病毒抑制的ART符合条件HIV感染者比例。
  • 研究还将评价客户和提供者对差异化服务递送的偏好及适应性HIV治疗的成本效果。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Of the 8 million people in South Africa living with HIV, 74% of persons living with HIV are on antiretroviral therapy (ART) and 65% are virally suppressed. Detectable viral load results in HIV-associated morbidity and mortality and HIV transmission. Patient barriers to care, such as missed wages, transport costs, and long wait times for clinic visits and ART refills, are associated with detectable viral load. HIV differentiated service delivery (DSD) has simplified ART delivery for clients who achieve viral suppression and engage in care. However, DSD needs adaptation to serve clients who are not engaged in care. METHODS: A Sequential Multiple Assignment Randomized Trial will be undertaken in KwaZulu-Natal, South Africa, to test adaptive ART delivery for persons with detectable viral load and/or who are not engaged in care. The types of differentiated service delivery (DSD) which will be examined in this study are clinic-based incentives, community-based smart lockers, and home delivery. The study plans to enroll up to 900 participants-people living with HIV, eligible for ART, and who are not engaged in care. The study aims to assess the proportion of ART-eligible persons living with HIV who achieve viral suppression at 18 months. The study will also evaluate the preferences of clients and providers for differentiated service delivery and evaluate the cost-effectiveness of adaptive HIV treatment for those who are not engaged in care. DISCUSSION: To increase population-level viral suppression, persons with detectable viral load need responsive DSD interventions. A Sequential Multiple Assignment Randomized Trial (SMART) design facilitates the evaluation of a stepped, adaptive approach to achieving viral suppression with "right-sized" interventions for patients most in need of effective and efficient HIV care delivery strategies. TRIAL REGISTRATION: ClinicalTrials.gov NCT05090150. Registered on October 22, 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. van Heerden A, Szpiro A, Ntinga X, et al. A Sequential Multiple Assignment Randomized Trial of scalable interventions for ART delivery in South Africa: the SMART ART study. Trials. 2023. PMID: 36647092. doi:10.1186/s13063-022-07025-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。